Company
Crossbow Therapeutics
| Industry | biotechnology company developing antibody therapies to treat a broad range of cancers |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| Crossbow Therapeutics | Series B | 2026-03-19 |
| Crossbow Therapeutics | Series A Financing | 2023-07-11 |